This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tianjin Institute of Pharmaceutical Research Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Zhixing Zhou: Innovator in Pharmaceutical Research
Introduction
Zhixing Zhou is a prominent inventor based in Tianjin, China. He has made significant contributions to the pharmaceutical field, particularly in the treatment of hyperuricemia and gout. His innovative work has led to the development of a unique compound that addresses these medical conditions.
Latest Patents
Zhixing Zhou holds 1 patent for his invention titled "Carboxylic acid URAT1 inhibitor containing diarylmethane structure, preparation method and use thereof." This patent focuses on a carboxylic acid urate transporter 1 (URAT1) inhibitor, which is crucial for developing medications aimed at treating hyperuricemia and gout. The invention includes a preparation method and a pharmaceutical composition that utilizes this inhibitor.
Career Highlights
Zhixing Zhou is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd. His work at this institute has been instrumental in advancing research and development in the pharmaceutical sector. His dedication to innovation has positioned him as a key figure in the industry.
Collaborations
Zhixing Zhou has collaborated with notable colleagues, including Qian Shang and Yuli Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Zhixing Zhou's contributions to pharmaceutical research exemplify the impact of innovation in addressing health challenges. His work continues to inspire advancements in the treatment of hyperuricemia and gout.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile